123 related articles for article (PubMed ID: 33345378)
1. Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran.
Radfar SR; Nematollahi P; Tayeri K; Dehghan H; Janani M; Higgs P; Mohsenifar S; Noroozi A
Drug Alcohol Rev; 2021 May; 40(4):572-579. PubMed ID: 33345378
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.
Noroozi M; Armoon B; Ghisvand H; Noroozi A; Karimy M; Bazrafshan MR; Marshall BDL; Dieji B
J Cosmet Dermatol; 2019 Feb; 18(1):258-262. PubMed ID: 29781249
[TBL] [Abstract][Full Text] [Related]
3. Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study.
Twahirwa Rwema JO; Nizeyimana V; Prata NM; Okonkwo NE; Mazzei AA; Muhirwa S; Rukundo A; Lucas L; Niyigena A; Makuza JD; Beyrer C; Baral SD; Kagaba A
Harm Reduct J; 2021 Dec; 18(1):130. PubMed ID: 34911554
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
5. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
[TBL] [Abstract][Full Text] [Related]
6.
Armenta RF; Collins KM; Strathdee SA; Bulterys MA; Munoz F; Cuevas-Mota J; Chiles P; Garfein RS
Int J Tuberc Lung Dis; 2017 Apr; 21(4):425-431. PubMed ID: 28284258
[TBL] [Abstract][Full Text] [Related]
7. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
[TBL] [Abstract][Full Text] [Related]
8. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.
Khezri M; Goldmann E; Tavakoli F; Karamouzian M; Shokoohi M; Mehmandoost S; Ghalekhani N; Haghdoost AA; Des Jarlais D; Mirzazadeh A; Sharifi H
Harm Reduct J; 2023 Oct; 20(1):145. PubMed ID: 37805505
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting.
Kizza FN; List J; Nkwata AK; Okwera A; Ezeamama AE; Whalen CC; Sekandi JN
BMC Infect Dis; 2015 Mar; 15():165. PubMed ID: 25879423
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
11. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
Semá Baltazar C; Kellogg TA; Boothe M; Loarec A; de Abreu E; Condula M; Fazito E; Raymond HF; Temmerman M; Luchters S
Int J Drug Policy; 2021 Apr; 90():103095. PubMed ID: 33429163
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: a sign of successful intervention?
Likindikoki SL; Mmbaga EJ; Leyna GH; Moen K; Makyao N; Mizinduko M; Mwijage AI; Faini D; Leshabari MT; Meyrowitsch DW
Harm Reduct J; 2020 Mar; 17(1):18. PubMed ID: 32209110
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
Toro-Tobón D; Berbesi-Fernández D
Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
[No Abstract] [Full Text] [Related]
16. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
[TBL] [Abstract][Full Text] [Related]
17. Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies.
Uusküla A; Rannap J; Weijler L; Abagiu A; Arendt V; Barrio G; Barros H; Brummer-Korvenkontio H; Casabona J; Croes E; Jarlais DD; Seguin-Devaux C; Dudás M; Eritsyan K; Folch C; Hatzakis A; Heimer R; Heinsbroek E; Hope V; Jipa R; Ķīvīte-Urtāne A; Levina O; Lyubimova A; Malczewski A; Matser A; McAuley A; Meireles P; Mravčík V; Op de Coul E; Ojavee SE; Parés-Badell O; Prins M; Pulido J; Romanyak E; Rosinska M; Seyler T; Stone J; Sypsa V; Talu A; Tarján A; Taylor A; Vickerman P; Vorobjov S; Dolan K; Wiessing L;
Addiction; 2023 Nov; 118(11):2177-2192. PubMed ID: 37991429
[TBL] [Abstract][Full Text] [Related]
18. Life-time HIV testing among people who inject drugs in Iran: results from the National Rapid Assessment and Response survey.
Roshanfekr P; Karimi SE; Narouee S; Moftakhar L; Vameghi M; Ali D; Higgs P; Soleimanvandiazar N
Front Public Health; 2023; 11():1253407. PubMed ID: 37915820
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
Mburu G; Chhoun P; Chann N; Tuot S; Mun P; Yi S
Subst Abuse Treat Prev Policy; 2019 Oct; 14(1):42. PubMed ID: 31623645
[TBL] [Abstract][Full Text] [Related]
20. Low HIV testing rate and its correlates among men who inject drugs in Iran.
Shokoohi M; Karamouzian M; Osooli M; Sharifi H; Fahimfar N; Haghdoost A; Zamani O; Mirzazadeh A
Int J Drug Policy; 2016 Jun; 32():64-9. PubMed ID: 27157980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
